News und Analysen
State Street Corporation Announces Date for Release of Second-Quarter 2022 Financial Results and Conference Call Webcast
State Street Corporation (NYSE: STT) plans to announce its second-quarter 2022 financial results on Friday, July 15, 2022 at approximately 7:30 a.m. ET. The results will be reviewed via webcast and
Moving to the Cloud? Management Platforms Are Critical
The accelerating global growth of private/hybrid cloud migration is leading more enterprises to adopt cloud management platforms (CMPs) to track and control their use of cloud resources, according
Kopin Receives $2M Development Contract for Defense In-Vehicle Display Imaging System
Kopin® Corporation (NASDAQ: KOPN), a leading provider of high-resolution microdisplays and sub-systems for Augmented Reality (AR) and Virtual Reality (VR) for use in defense, enterprise and
Marc O’Polo Sews Up Future of Work with Citrix®
As one of the world’s premium brands for casual wear, Marc O’Polo is always thinking ahead and on top of trends. While many companies viewed the shift to remote work as a pandemic-inspired fad, the
Marc O’Polo Sews Up Future of Work with Citrix®
As one of the world’s premium brands for casual wear, Marc O’Polo is always thinking ahead and on top of trends. While many companies viewed the shift to remote work as a pandemic-inspired fad, the
EVRAZ plc publishes its Modern Slavery Act Transparency Statement for 2021
Offer Document Regarding Philip Morris Holland Holdings B.V.’s Recommended Cash Offer to the Shareholders of Swedish Match AB Made Public
This announcement is not an offer, whether directly or indirectly, in Australia, Hong Kong, Japan, New Zealand, or South Africa or in any other jurisdiction where such offer pursuant to legislation
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
Roivant Sciences and Pfizer today announced the unveiling of Priovant Therapeutics, dedicated to developing and commercializing novel therapies for autoimmune diseases with the greatest morbidity
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
Roivant Sciences and Pfizer today announced the unveiling of Priovant Therapeutics, dedicated to developing and commercializing novel therapies for autoimmune diseases with the greatest morbidity
DGAP-Adhoc: VERBIO Vereinigte BioEnergie AG: Significant increase in EBITDA forecast for the financial year 2021/2022 to approximately EUR 500 million - strong demand for advanced 2nd generation biofuels
DGAP-Adhoc: VERBIO Vereinigte BioEnergie AG: Significant increase in EBITDA forecast for the financial year 2021/2022 to approximately EUR 500 million - strong demand for advanced 2nd generation biofuels
Bureau Veritas Acquires Advanced Testing Laboratory, a US Leader in Scientific Sourcing
Bureau Veritas, a world leader in testing, inspection and certification, announced the acquisition of Advanced Testing Laboratory (ATL), a leader in scientific sourcing services for the North
Transgene and BioInvent Announce Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BT-001 in Combination with KEYTRUDA®
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq
Fifth Third Releases Stress Capital Buffer Requirement
Fifth Third Bancorp (Nasdaq: FITB) today released its indicative stress capital buffer requirement resulting from the Federal Reserve Board’s (“FRB”) 2022 Comprehensive Capital Analysis and Review
Fifth Third Releases Stress Capital Buffer Requirement
Fifth Third Bancorp (Nasdaq: FITB) today released its indicative stress capital buffer requirement resulting from the Federal Reserve Board’s (“FRB”) 2022 Comprehensive Capital Analysis and Review
Granite REIT Notice of Conference Call for Second Quarter 2022 Results
Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) expects to announce its financial results for the second quarter ended June 30, 2022 after the close of markets on
Morgan Stanley Announces 11% Dividend Increase and Authorization of a $20 Billion Multi-Year Common Equity Share Repurchase Program
Morgan Stanley (NYSE: MS) announced that it will increase its quarterly common stock dividend to $0.775 per share from the current $0.70 per share, beginning with the common dividend expected to be
State Street Corporation Announces Preliminary Stress Capital Buffer Requirement and the Intention to Increase its Quarterly Common Stock Dividend to $0.63 per share
State Street Corporation (NYSE: STT) today announced its preliminary stress capital buffer (SCB) requirement of 2.5%, effective October 1, 2022, and the intention to increase its quarterly common
NIKE, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Results
NIKE, Inc. (NYSE:NKE) today reported financial results for its fiscal 2022 fourth quarter and full year ended May 31, 2022.
-
Fourth quarter reported revenues were $12.2 billion, down 1 percent
NIKE, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Results
NIKE, Inc. (NYSE:NKE) today reported financial results for its fiscal 2022 fourth quarter and full year ended May 31, 2022.
-
Fourth quarter reported revenues were $12.2 billion, down 1 percent
New Hewlett Packard Enterprise Partner Program Fuels As-a-Service Growth for Global Partner Ecosystem
HPE Global Partner Summit 2022 – Hewlett Packard Enterprise (NYSE: HPE) today announced a new partner program, HPE Partner Ready Vantage. Building upon the award winning HPE Partner Ready program
DGAP-News: Siemens Healthineers AG: Publication of a capital market information